Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Resurrect Bio

London AgriTech Startup Resurrect Bio Secures €8.8 Million in Series A Funding Led by Corteva

May 14, 2026 by James O'Brien

Resurrect Bio, a London-based agricultural BioTech startup, closed an oversubscribed Series A funding round at €8.8 million ($10.3 million), led by Corteva through its Corteva Catalyst platform. The company had made an initial close of over €6.8 million in February 2026.

Categories Funding Tags €5M–€20M, Agritech, Resurrect Bio, Series A Leave a comment
Browse by Country

Latest

Norwegian-Swedish Startup Vidda Launches AI Platform to Streamline Compliance in Regulated IndustriesNov 16, 2026
Blackbird Coffee Lands €16 Million Series A to Expand Workplace Coffee Platform Across EuropeNov 16, 2026
Romanian Fintech BT Broker Launches Free AI-Powered CASCO Vehicle Inspection ToolNov 16, 2026
Swedish workforce management platform Quinyx cuts 14% of staff in restructuring pushNov 16, 2026
ElevenLabs Reaches €19 Billion Valuation After Secondary Share Sale, Three Years After European Pre-Seed BackingNov 16, 2026

EU Markets

European Startups Navigate a Week of Big Money Moves, Regulatory Shifts, and Market TurbulenceNov 13, 2026
Europe's Financial Pulse: AI Bets, Rate Signals, and What Founders Need to Know This WeekNov 6, 2026
European Markets Flash Caution Signals: What This Week's Financial Turbulence Means for Startup FoundersOct 30, 2026
European Startups, Brace Yourselves: Rate Pressures, AI Disruption, and a €550M Legal Tech Unicorn Define This Week's Financial LandscapeOct 23, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.